347 related articles for article (PubMed ID: 27288062)
21. Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution.
Rivard GE; St Louis J; Lacroix S; Champagne M; Rock G
Haemophilia; 2003 Nov; 9(6):711-6. PubMed ID: 14750937
[TBL] [Abstract][Full Text] [Related]
22. Haemophilia part 1: an introduction.
Khair K
Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
[No Abstract] [Full Text] [Related]
23. Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B.
Levine PH; Britten AF
Ann Intern Med; 1973 Feb; 78(2):195-201. PubMed ID: 4630527
[No Abstract] [Full Text] [Related]
24. Issues in making a therapeutic choice: recombinant and/or human-derived products.
Aledort LM
Haemophilia; 2001 Jan; 7(1):89-90. PubMed ID: 11136386
[No Abstract] [Full Text] [Related]
25. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
26. A golden age for Haemophilia treatment?
Makris M; Hermans C
Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
[No Abstract] [Full Text] [Related]
27. Hemophilia.
Kashyap R; Choudhry VP
Indian Pediatr; 2000 Jan; 37(1):45-53. PubMed ID: 10745388
[No Abstract] [Full Text] [Related]
28. The fix is in.
Pemberton S
Sci Am; 2015 Jan; 312(1):S11. PubMed ID: 25597118
[No Abstract] [Full Text] [Related]
29. Substitution treatment of hemophilia a and b.
Duckert F
Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
[TBL] [Abstract][Full Text] [Related]
30. A rare case of late development of inhibitor in haemophilia B with a complex course, and review of the literature.
Soto I; Martínez D; Ávila LF; Bernardo Á
Haemophilia; 2018 May; 24(3):e125-e128. PubMed ID: 29488670
[No Abstract] [Full Text] [Related]
31. A therapeutic alternative for haemophiliacs with inhibitors.
Schulman S
Acta Paediatr; 1992; 81(6-7):564-5. PubMed ID: 1392376
[No Abstract] [Full Text] [Related]
32. Recombinant clotting factor concentrates.
Lusher JM
Baillieres Clin Haematol; 1996 Jun; 9(2):291-303. PubMed ID: 8800506
[No Abstract] [Full Text] [Related]
33. Evolving Complexity in Hemophilia Management.
Croteau SE
Pediatr Clin North Am; 2018 Jun; 65(3):407-425. PubMed ID: 29803274
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
Levine PH
N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
[No Abstract] [Full Text] [Related]
35. The promise of third-generation recombinant therapy and gene therapy.
Manno CS
Semin Hematol; 2003 Jul; 40(3 Suppl 3):23-8. PubMed ID: 14690065
[TBL] [Abstract][Full Text] [Related]
36. Haemophilia.
Biggs R
Proc R Soc Med; 1969 Sep; 62(9):913-4. PubMed ID: 4241884
[No Abstract] [Full Text] [Related]
37. Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
Fukutake K
Semin Thromb Hemost; 2000; 26(1):29-32. PubMed ID: 10805278
[TBL] [Abstract][Full Text] [Related]
38. [Substitution treatment in hemophilia. Critical measures and complications].
Schimpf K
Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
[No Abstract] [Full Text] [Related]
39. Hemophilia in childhood.
McNeill GF; Schwartz E
Pa Med; 1975 Jan; 78(1):51-3. PubMed ID: 1128902
[No Abstract] [Full Text] [Related]
40. Home treatment of haemophilia and Christmas disease: five years' experience.
Rizza CR; Spooner RJ
Br J Haematol; 1977 Sep; 37(1):53-66. PubMed ID: 588479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
